Testing effectiveness (Phase 2)Study completedNCT05382312
What this trial is testing
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis
Who this might be right for
Tuberculosis
GlaxoSmithKline 127